These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 15325007)
1. Differential gene expression in the T-helper lymphocytes of obstructive sleep apnea patients treated with nasal continuous positive airway pressure (nCPAP). Shadan FF; Jalowayski A; Fahrenholz J; Dawson A; Kline L Med Hypotheses; 2004; 63(4):630-2. PubMed ID: 15325007 [TBL] [Abstract][Full Text] [Related]
2. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Dyugovskaya L; Lavie P; Lavie L Ann N Y Acad Sci; 2005 Jun; 1051():340-50. PubMed ID: 16126976 [TBL] [Abstract][Full Text] [Related]
3. Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness. Sampol G; Rodés G; Romero O; Jurado MJ; Lloberes P Respir Med; 2007 Mar; 101(3):461-6. PubMed ID: 16919928 [TBL] [Abstract][Full Text] [Related]
5. Evidence of interrelated side effects with reduced compliance in patients treated with nasal continuous positive airway pressure. Baltzan MA; Elkholi O; Wolkove N Sleep Med; 2009 Feb; 10(2):198-205. PubMed ID: 18314388 [TBL] [Abstract][Full Text] [Related]
6. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Akinnusi ME; Paasch LL; Szarpa KR; Wallace PK; El Solh AA Respiration; 2009; 77(1):25-31. PubMed ID: 18812691 [TBL] [Abstract][Full Text] [Related]
7. Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment. Chin K; Nakamura T; Takahashi K; Sumi K; Matsumoto H; Niimi A; Fukuhara S; Mishima M; Nakamura T J Hypertens; 2006 Oct; 24(10):2091-9. PubMed ID: 16957571 [TBL] [Abstract][Full Text] [Related]
8. Nasal cytology: a marker of clinically silent inflammation in patients with obstructive sleep apnea and a predictor of noncompliance with nasal CPAP therapy. Shadan FF; Jalowayski AA; Fahrenholz J; Kline LE; Dawson A J Clin Sleep Med; 2005 Jul; 1(3):266-70. PubMed ID: 17566187 [TBL] [Abstract][Full Text] [Related]
9. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Yamamoto Y; Fujiuchi S; Hiramatsu M; Nishigaki Y; Takeda A; Fujita Y; Yamazaki Y Respiration; 2008; 76(4):377-85. PubMed ID: 18577878 [TBL] [Abstract][Full Text] [Related]
10. [Risk of interrupting nocturnal nasal continuous positive airway pressure (nCPAP) in patients with obstructive sleep apnea]. Dette F; Rolke M; Rückert P; Wulf H; Koehler U Dtsch Med Wochenschr; 2010 Apr; 135(17):868-9. PubMed ID: 20408107 [TBL] [Abstract][Full Text] [Related]
11. Mouth breathing in obstructive sleep apnea prior to and during nasal continuous positive airway pressure. Ruhle KH; Nilius G Respiration; 2008; 76(1):40-5. PubMed ID: 18042974 [TBL] [Abstract][Full Text] [Related]
12. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091 [TBL] [Abstract][Full Text] [Related]
13. Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Morris LG; Setlur J; Burschtin OE; Steward DL; Jacobs JB; Lee KC Am J Rhinol; 2006; 20(2):133-7. PubMed ID: 16686374 [TBL] [Abstract][Full Text] [Related]
14. [Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome]. Wang YN; Yang Y; Luo YQ; Chen LL Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):666-9. PubMed ID: 16708805 [TBL] [Abstract][Full Text] [Related]
15. [Quality of life in patients with obstructive sleep apnea]. Kasibowska-Kuźniar K; Jankowska R; Kuźniar T Pol Merkur Lekarski; 2004 Nov; 17(101):427-30. PubMed ID: 15754624 [TBL] [Abstract][Full Text] [Related]
16. Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. Devouassoux G; Lévy P; Rossini E; Pin I; Fior-Gozlan M; Henry M; Seigneurin D; Pépin JL J Allergy Clin Immunol; 2007 Mar; 119(3):597-603. PubMed ID: 17261329 [TBL] [Abstract][Full Text] [Related]
17. Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea. Sumi K; Chin K; Takahashi K; Nakamura T; Matsumoto H; Niimi A; Mishima M QJM; 2006 Aug; 99(8):545-53. PubMed ID: 16861714 [TBL] [Abstract][Full Text] [Related]
18. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125 [TBL] [Abstract][Full Text] [Related]
19. Frequency of upper airway symptoms before and during continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. Kreivi HR; Virkkula P; Lehto J; Brander P Respiration; 2010; 80(6):488-94. PubMed ID: 20881373 [TBL] [Abstract][Full Text] [Related]
20. Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Reinhart WH; Oswald J; Walter R; Kuhn M Clin Hemorheol Microcirc; 2002; 27(3-4):201-7. PubMed ID: 12454377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]